BALAXI PHARMACEUTICALS LIMITED

BALAXI PHARMACEUTICALS LIMITED (NSE/BSE: BALAXI) is an Indian publicly listed company quoted on the National Stock Exchange (NSE). The company operates in healthcare, a sector that combines regulated pricing with long-run demand growth from a rising domestic patient base. Its securities trade under ISIN INE618N01022. It is listed under the BE series. As of the most recent update, BALAXI PHARMACEUTICALS LIMITED carries an equity market capitalisation of approximately ₹130 Cr, which places it among the tracked constituents of the Healthcare sector on Indian exchanges. Detailed shareholding-pattern disclosures are published quarterly by BALAXI PHARMACEUTICALS LIMITED via stock-exchange filings. For investors and researchers tracking healthcare listings, BALAXI provides a window into how listed Indian capital is being allocated within the sector — by promoters, by foreign institutions, and by retail participants. This page consolidates BALAXI PHARMACEUTICALS LIMITED's core registration, listing and shareholding data into a single open record. Figures are refreshed weekly from the official NSE archives and BSE scrip master; the company's own filings remain the authoritative source for governance, financial and disclosure data.